Boothy >> the rise today probably came as a result of the buy note on ELA that was issued this morning.
it wasn't listed under the normal buy / sell note columns, it was liested on the "consolodated activty", with a buy rec at $12.90.
the reason was because Amgen offered $2.2b plus debt for another US pharma, after the close last night, marking their sp up 54%,
there's alot of consolodation now in the US and ELA are prime meat for this type of activity, potential blockbuster drug on the cusp of approval.
so it was a knee jerk to the amgen deal, IMHO,